RapidAI receives FDA 510(k) for another pulmonary embolism tool
Today Headline,
RapidAI, a health tech company specializing in imaging analysis software, announced it received FDA 510(k) clearance for its…
RapidAI, a health tech company specializing in imaging analysis software, announced it received FDA 510(k) clearance for its…
RapidAI, a health tech company specializing in imaging analysis software, announced it received FDA 510(k) clearance for its…
RapidAI, une société de technologie de la santé spécialisée dans les logiciels d’analyse d’imagerie, a annoncé avoir reçu l’autor…
Rapid RV/LV uses AI to calculate the ratio between the right and left ventricles, an indicator of pulmonary embolism severity.